Sangamo Therapeutics News, Sangamo Therapeutics Quote, SGMO Quote

Sangamo Therapeutics (NQ:SGMO) Delayed: 0.51 --0 (-0%)

Prev. Close

$0.51

Open

$0.53

52 Wk High

$9.91

52 Wk Low

$3.10

Day High

$0.56

Day Low

$0.48

P/E

N/A

EPS

$-0.48

Volume

1,267,220

Friends, Peers and Foes (?): VYGR LLY (more...)

Apr 22, 2024 04:35 PM Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society
Apr 19, 2024 04:15 PM Form ARS SANGAMO THERAPEUTICS, For: Dec 31
Apr 19, 2024 04:02 PM Form DEF 14A SANGAMO THERAPEUTICS, For: Jun 04
Apr 5, 2024 04:00 PM Form SC 13G/A SANGAMO THERAPEUTICS, Filed by: WASATCH ADVISORS LP
Apr 3, 2024 05:18 PM Form PRE 14A SANGAMO THERAPEUTICS, For: Jun 04
Mar 25, 2024 05:04 PM Form 8-K SANGAMO THERAPEUTICS, For: Mar 21
Mar 25, 2024 04:02 PM Form 424B5 SANGAMO THERAPEUTICS,
Mar 22, 2024 08:05 AM Sangamo Therapeutics (SGMO) Announces Pricing of $24.0 Million Registered Direct Offering
Mar 22, 2024 08:05 AM Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering
Mar 19, 2024 06:36 AM Sangamo BioSciences (SGMO) PT Raised to $5 at H.C. Wainwright on positive outlook for the SIFTER platform

Entities mentioned with SGMO